Meihua Medical is a high-tech enterprise that develops and produces microbial medical instruments and diagnostic reagents. Bacterial vaginosis (BV) rapid detection series, liquid-based cell smear series, plate medium series and more than 20 products in six series. Meihua Medical recently announced that it has completed its B round of financing exceeding RMB 100 million. This round of financing was jointly led by Eight Roads Capital and Shanlan Capital, followed by Zhuhai Gaoxin Financial Investment and Qianhe Capital. Zhonghe Capital acted as the exclusive financial advisor for this round of financing. This round of financing will be mainly used for the company’s product research and development investment, while accelerating the market promotion of its own brand, and further expanding the company’s market share in the microbial diagnosis industry.
This article is transferred from: https://www.itjuzi.com/investevent/13726193
This site is only for collection, and the copyright belongs to the original author.